Robert Mass's most recent trade in Intuitive Machines Inc - Ordinary Shares - Class A was a trade of 44,544 Class A Common Stock done . Disclosure was reported to the exchange on June 6, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Intuitive Machines Inc - O... | Robert L. Masson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 44,544 | 62,865 | - | 0 | Class A Common Stock | |
Intuitive Machines Inc - O... | Robert L. Masson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 18,321 | 18,321 | - | 0 | Class A Common Stock | |
Latham Group Inc | Robert L. Masson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2022 | 151,807 | 151,807 | - | - | Stock option (right to buy) | |
Latham Group Inc | Robert L. Masson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2022 | 54,592 | 54,592 | - | 0 | Common Stock, par value $0.0001 per share | |
MEI Pharma Inc | Robert D. Mass | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2020 | 230,000 | 230,000 | - | - | Stock Option (Right to Buy) |